- Electroporation of Peri-Mitral Atrial Flutter in Patient With Mechanical Prosthetic Valve
-
Urbanek P, Orczykowski M, Bodalski R, Hasiec A, Jaworski K, Pręgowski J, Prokopowicz D, Szumowski
- KMID: 2559131
- Korean Circ J.
- 2024 Sep;54(9):587-589.
- doi: 10.4070/kcj.2024.0069
-
- CITED
-
- Close
- SHARE
-
- Close
- SGLT2 Inhibitor, an Agent for Diabetes, Heart, Kidney… and Stroke
-
Yang T, Lee J, Oh J
- KMID: 2559128
- Korean Circ J.
- 2024 Sep;54(9):562-564.
- doi: 10.4070/kcj.2024.0214
-
- CITED
-
- Close
- SHARE
-
- Close
- Exploring New Combination Strategy of Lipid-Lowering Therapies for Primary Prevention of Cardiovascular Disease
-
Cho JH, Cho EJ, Jeong YH
- KMID: 2559126
- Korean Circ J.
- 2024 Sep;54(9):545-548.
- doi: 10.4070/kcj.2024.0195
-
- CITED
-
- Close
- SHARE
-
- Close
- Drug-Coated Balloon Treatment for De Novo Coronary Lesions: Current Status and Future Perspectives
-
Her AY, Shin ES
- KMID: 2559124
- Korean Circ J.
- 2024 Sep;54(9):519-533.
- doi: 10.4070/kcj.2024.0148
The outstanding development in contemporary medicine, highlighted by percutaneous coronary intervention (PCI), was achieved through the adoption of drug-eluting stents (DESs). Although DES is the established therapy for patients undergoing... -
- CITED
-
- Close
- SHARE
-
- Close
- Korean Multicenter Registry of ELUVIA Stent for Femoropopliteal Artery Disease: K-ELUVIA Registry
-
Kim J, Ko YG, Lee SJ, Ahn CM, Rha SW, Choi CU, Min PK, Park JK, Jang JY, Youn YJ, Kang TS, Yoon CH, Choi D
- KMID: 2559129
- Korean Circ J.
- 2024 Sep;54(9):565-576.
- doi: 10.4070/kcj.2024.0038
Background and Objectives: The K-ELUVIA study aimed to investigate the clinical effectiveness and safety of Eluvia™, a polymer-coated, paclitaxel-eluting stent, for femoropopliteal artery disease using data from a prospective Korean... -
- CITED
-
- Close
- SHARE
-
- Close
- Sex-Specific Susceptibility Loci Associated With Coronary Artery Aneurysms in Patients With Kawasaki Disease
-
Kim JJ, Hong YM, Yun SW, Lee KY, Yoon KL, Han MK, Kim GB, Kil HR, Song MS, Lee HD, Ha KS, Jun HO, Yu JJ, Jang GY, Lee JK, on behalf of the Korean Kawasaki Disease Genetics Consortium
- KMID: 2559130
- Korean Circ J.
- 2024 Sep;54(9):577-586.
- doi: 10.4070/kcj.2023.0244
Background and Objectives: Kawasaki disease (KD) is an acute vasculitis that primarily affects children under age 5 years. Approximately 20–25% of untreated children with KD and 3–5% of those treated... -
- CITED
-
- Close
- SHARE
-
- Close
- Cardiovascular Outcomes of Sodium-Glucose Cotransporter-2 Inhibitors Therapy in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease: A Systematic Review and Updated Meta-Analysis
-
Felix N, Gauza MM, Teixeira L, Guisso MES, Nogueira A, Dagostin CS, Godoi A, Ribeiro SAG, Duque JC, Moura-Neto JA, Cardoso R
- KMID: 2559127
- Korean Circ J.
- 2024 Sep;54(9):549-561.
- doi: 10.4070/kcj.2023.0241
Background and Objectives: The efficacy of sodium-glucose cotransporter-2 inhibitors (SGLT2i) may depend on renal function, and this raises theoretical concern over its effects on cardiovascular outcomes in patients with type... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of Statin With Ezetimibe Combination Therapy Versus Statin Monotherapy for Primary Prevention in Middle-Aged Adults
-
Cha JJ, Hong SJ, Lim S, Kim JH, Joo HJ, Park JH, Yu CW, Lim DS, Kim JY, Jeong JO, Shin JH, Shim CY, Lee JY, Lim YH, Park SH, Cho EJ, Kim H, Lee J, Sung KC, on behalf of the Korean Vascular Society
- KMID: 2559125
- Korean Circ J.
- 2024 Sep;54(9):534-544.
- doi: 10.4070/kcj.2024.0036
Background and Objectives: Lipid lowering therapy is essential to reduce the risk of major cardiovascular events; however, limited evidence exists regarding the use of statin with ezetimibe as primary prevention... -
- CITED
-
- Close
- SHARE
-
- Close
